NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIMH E-080-1999-0-BE-12 METHODS OF PROLONGING TRANSPLANT SURVIVAL USING IMMUNOTOXINS AND CO- STIMULATION BLOCKADE OF CD154 AND CD28 BE EP 00904230.0 Abandoned
NIMH E-080-1999-0-DE-07 METHODS OF PROLONGING TRANSPLANT SURVIVAL USING IMMUNOTOXINS AND CO- STIMULATION BLOCKADE OF CD154 AND CD28 DE EP 00904230.0 Abandoned
NIMH E-080-1999-0-FR-18 METHODS OF PROLONGING TRANSPLANT SURVIVAL USING IMMUNOTOXINS AND CO- STIMULATION BLOCKADE OF CD154 AND CD28 FR EP 00904230.0 Abandoned
NIMH E-080-1999-0-CH-13 METHODS OF PROLONGING TRANSPLANT SURVIVAL USING IMMUNOTOXINS AND CO- STIMULATION BLOCKADE OF CD154 AND CD28 CH EP 00904230.0 Abandoned
NIMH E-080-1999-0-GB-19 METHODS OF PROLONGING TRANSPLANT SURVIVAL USING IMMUNOTOXINS AND CO- STIMULATION BLOCKADE OF CD154 AND CD28 GB EP 00904230.0 Abandoned
NIMH E-080-1999-0-NL-25 METHODS OF PROLONGING TRANSPLANT SURVIVAL USING IMMUNOTOXINS AND CO- STIMULATION BLOCKADE OF CD154 AND CD28 NL EP 00904230.0 Abandoned
NIMH E-080-1999-0-MC-24 METHODS OF PROLONGING TRANSPLANT SURVIVAL USING IMMUNOTOXINS AND CO- STIMULATION BLOCKADE OF CD154 AND CD28 MC EP 00904230.0 Abandoned
NIMH E-080-1999-0-LU-08 METHODS OF PROLONGING TRANSPLANT SURVIVAL USING IMMUNOTOXINS AND CO- STIMULATION BLOCKADE OF CD154 AND CD28 LU EP 00904230.0 Abandoned
NIMH E-080-1999-0-LI-23 METHODS OF PROLONGING TRANSPLANT SURVIVAL USING IMMUNOTOXINS AND CO- STIMULATION BLOCKADE OF CD154 AND CD28 LI EP 00904230.0 Abandoned
NIMH E-080-1999-0-IE-21 METHODS OF PROLONGING TRANSPLANT SURVIVAL USING IMMUNOTOXINS AND CO- STIMULATION BLOCKADE OF CD154 AND CD28 IE EP 00904230.0 Abandoned
NIMH E-080-1999-0-GR-20 METHODS OF PROLONGING TRANSPLANT SURVIVAL USING IMMUNOTOXINS AND CO- STIMULATION BLOCKADE OF CD154 AND CD28 GR EP 00904230.0 Abandoned
NIMH E-080-1999-0-IT-22 METHODS OF PROLONGING TRANSPLANT SURVIVAL USING IMMUNOTOXINS AND CO- STIMULATION BLOCKADE OF CD154 AND CD28 IT EP 00904230.0 Abandoned
NCI E-210-1998-0-IE-08 Aspartic Protease Inhibitors, Compositions, and Associated Therapeutic Methods IE EP 00903134.5 Abandoned
NCI E-210-1998-0-EP-03 Aspartic Protease Inhibitors, Compositions, and Associated Therapeutic Methods EP National Stage 00903134.5 Abandoned
NCI E-210-1998-0-GB-07 Aspartic Protease Inhibitors, Compositions, and Associated Therapeutic Methods GB EP 00903134.5 Abandoned
NCI E-210-1998-0-CH-06 Aspartic Protease Inhibitors, Compositions, and Associated Therapeutic Methods CH EP 00903134.5 Abandoned
NCI E-029-1990-0-HK-11 In Vitro Method of Determining the Presence of a Protein in an Isolated Biological Sample HK National Stage 00100071.2 Abandoned
NIMH E-080-1999-0-AU-03 METHODS OF PROLONGING TRANSPLANT SURVIVAL USING IMMUNOTOXINS AND CO- STIMULATION BLOCKADE OF CD154 AND CD28 AU National Stage 26017/00 Abandoned
NCI E-231-1998-0-PCT-02 Lentivirus Vector System PCT PCT PCT/US00/00390 Abandoned
NCI E-210-1998-0-PCT-02 Aspartic Protease Inhibitors, Compositions, and Associated Therapeutic Methods PCT PCT PCT/US00/00265 Expired
NIMH E-080-1999-0-PCT-02 METHODS OF PROLONGING TRANSPLANT SURVIVAL USING IMMUNOTOXINS AND CO- STIMULATION BLOCKADE OF CD154 AND CD28 PCT PCT PCT/US00/00284 Expired
NCI E-021-1999-0-PCT-02 The CD4-CCR5 Interaction as a Target for Inhibitors of HIV Infection PCT PCT PCT/US00/00417 Abandoned
NIMH E-080-1999-0-CA-06 METHODS OF PROLONGING TRANSPLANT SURVIVAL USING IMMUNOTOXINS AND CO- STIMULATION BLOCKADE OF CD154 AND CD28 CA National Stage 2358435 Abandoned
NHGRI E-101-1997-0-US-02 PROBE-BASED ANALYSIS OF HETEROZYGOUS MUTATIONS USING TWO-COLOR LABELLING US CON 09/477,871 6342355 Expired PDF
NCI E-068-2000-0-US-01 Molecules That Influence Pathogen Resistance US 60/174,470 Abandoned
NINDS E-171-1999-0-US-01 High-Speed Interlaced Spin Echo Magnetic Resonance Imaging US 60/173,563 Abandoned
NICHD E-013-2000-0-US-01 Improved Process Development of 17alpha-acetoxy-11beta-(4-(N,N- dimethylamino)phenly)-21-Methoxy-19-norpregna-4,9-diene-3,20-dione US 60/173,470 Abandoned
NCI E-148-1998-0-US-01 Molecular Clones With Mutated HIV GAG/POL and SIV GAG Genes US 60/173,036 Abandoned
NCI E-260-1998-1-US-01 System and Method for Representing Knowledge in a Distributed System US CIP 09/470,684 Abandoned
NCI E-151-1998-0-CA-04 Water-Insoluble Drug Delivery System CA National Stage 2356959 Abandoned
NCI E-151-1998-0-EP-05 Water-Insoluble Drug Delivery System EP National Stage 99965336.3 Abandoned
NCI E-151-1998-0-AU-03 Water-Insoluble Drug Delivery System AU National Stage 31278/00 Abandoned
NCI E-151-1998-0-US-07 Water-Insoluble Drug Delivery System US National Stage 09/868,858 6682758 Abandoned PDF
NCI E-077-1999-0-US-02 Agents That Bind to and Inhibit Human Cytochrome P450 2C8, 2C9, 2C18, and 2C19 US ORD 09/469,655 6623960 Expired PDF
NCI E-194-1998-0-US-02 Calcium Channel Compositions and Methods of Use Thereof US ORD 09/470,443 6441156 Abandoned PDF
NCI E-067-1997-0-US-07 Novel Nitric oxide-releasing amidine and enamine-derived diazeniumdiol ates compositions and uses thereof and methods of making same. US National Stage 09/446,653 6232336 Abandoned PDF
NCI E-151-1998-0-PCT-02 Water-Insoluble Drug Delivery System PCT PCT PCT/US1999/030631 Expired
NCI E-151-1998-0-JP-06 Water-Insoluble Drug Delivery System JP National Stage 2000-589161 Abandoned
NIAID E-087-1997-0-US-04 STRL33, A Human Accessory Factor Associated With HIV Infection US National Stage 09/402,275 Abandoned
NCI E-052-1995-1-US-09 Induction of an Activated Myeloid Dendritic Cell Phenotype US CON 09/469,589 Abandoned
NCI E-061-2000-0-US-01 Compositions and Methods For Treatment of Breast Cancer US 60/171,928 Abandoned
NIAID E-141-1995-0-US-08 Method of Decreasing Radiation or Radio-Mimetic Chemotherapy For Hematopoietic Pluripotent Cell Engraftment US DIV 09/468,727 6423311 Abandoned PDF
NIEHS E-009-1994-1-US-01 Method For Modulating Processes Mediated by Farnesoid Activated Receptors US ORD 09/469,721 6184353 Expired PDF
NIDCR E-177-1996-0-US-03 SERUM FREE CELL GROWTH MEDIUM US ORD 09/468,562 Abandoned
NEI E-027-2000-1-US-01 Method for Ameliorating an Allergic Reaction US CIP 09/470,382 Expired
NIAID E-099-1997-0-US-04 RECOMBINANT PROTEINS OF A PAKISTANI STRAIN OF HEPATITIS E AND THEIR USE IN DIAGNOSTIC METHODS AND VACCINES US DIV 09/468,536 Abandoned
NIAID E-099-1997-0-US-03 RECOMBINANT PROTEINS OF A PAKISTANI STRAIN OF HEPATITIS E AND THEIR USE IN DIAGNOSTIC METHODS AND VACCINES US DIV 09/467,874 Abandoned
NIAID E-221-2000-1-US-01 Live Attenuated Newcastle Disease Vaccine US 60/171,072 Abandoned
NHGRI E-274-1999-0-US-01 Methods of Making and Using Tissue Microarrays US 60/171,262 Abandoned
NHGRI E-273-1999-0-US-01 High-Throughput, Automated tissue Microarrays Construction, And Digital Image Analysis US 60/170,461 Abandoned